Results 1 to 10 of about 9,818,371 (382)

Nutritional Support in Pancreatic Diseases. [PDF]

Nutrients, 2022
This review summarizes the main pancreatic diseases from a nutritional approach. Nutrition is a cornerstone of pancreatic disease and is sometimes undervalued.
Cañamares-Orbís P, García-Rayado G, Alfaro-Almajano E.   +2 more
europepmc   +2 more sources

Understanding Necroptosis in Pancreatic Diseases. [PDF]

Biomolecules, 2022
Intermediate between apoptosis and necrosis, necroptosis is a regulated caspase-independent programmed cell death that induces an inflammatory response and mediates cancer development.
He R, Wang Z, Dong S, Chen Z, Zhou W.
europepmc   +2 more sources

Development of a Novel Evaluation Method for Endoscopic Ultrasound-Guided Fine-Needle Biopsy in Pancreatic Diseases Using Artificial Intelligence

Diagnostics, 2022
We aimed to develop a new artificial intelligence (AI)-based method for evaluating endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) specimens in pancreatic diseases using deep learning and contrastive learning.
Takuya Ishikawa, Masato Hayakawa, Hirotaka Suzuki, Eizaburo Ohno, Yasuyuki Mizutani, Tadashi Iida, Mitsuhiro Fujishiro, Hiroki Kawashima, Kazuhiro Hotta   +8 more
doaj   +2 more sources

Application of exosomes in the diagnosis and treatment of pancreatic diseases. [PDF]

Stem Cell Res Ther, 2022
Pancreatic diseases, a serious threat to human health, have garnered considerable research interest, as they are associated with a high mortality rate.
Han L, Zhao Z, Yang K, Xin M, Zhou L, Chen S, Zhou S, Tang Z, Ji H, Dai R.   +9 more
europepmc   +2 more sources

Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases. [PDF]

Nutrients, 2022
Urolithin A (Uro A) is a dietary metabolite of the intestinal microbiota following the ingestion of plant-based food ingredients ellagitannins and ellagic acid in mammals.
Li K, Xiao Y, Bian J, Han L, He C, El-Omar E, Gong L, Wang M.   +7 more
europepmc   +2 more sources

Microbiota in Pancreatic Diseases: A Review of the Literature. [PDF]

J Clin Med, 2021
The gut microbiota is a critical element in the balance between human health and disease. Its impairment, defined as dysbiosis, is associated with gastroenterological and systemic diseases.
Schepis T, De Lucia SS, Nista EC, Manilla V, Pignataro G, Ojetti V, Piccioni A, Gasbarrini A, Gasbarrini A, Franceschi F, Candelli M.   +10 more
europepmc   +2 more sources

Role of Fibre in Nutritional Management of Pancreatic Diseases [PDF]

Nutrients, 2019
The role of fibre intake in the management of patients with pancreatic disease is still controversial. In acute pancreatitis, a prebiotic enriched diet is associated with low rates of pancreatic necrosis infection, hospital stay, systemic inflammatory ...
Badiali, Danilo, Bruno, Giovanni, Ribichini, Emanuela, Rossi, Sara, Sacchi, MARIA CARLOTTA, Severi, Carola, Stigliano, Serena, Zaccari, Piera   +7 more
core   +2 more sources

Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target

Frontiers in Nutrition, 2022
Pancreatic-related disorders such as pancreatitis, pancreatic cancer, and type 1 diabetes mellitus (T1DM) impose a substantial challenge to human health and wellbeing. Even though our understanding of the initiation and progression of pancreatic diseases
Tao Zhang, Tao Zhang, Tao Zhang, Guangqi Gao, Guangqi Gao, Guangqi Gao, Hafiz Arbab Sakandar, Hafiz Arbab Sakandar, Hafiz Arbab Sakandar, Lai-Yu Kwok, Lai-Yu Kwok, Lai-Yu Kwok, Zhihong Sun, Zhihong Sun, Zhihong Sun   +14 more
doaj   +2 more sources

The association between pancreatic diseases and pancreatic fat content: a cross-sectional study from the UK Biobank [PDF]

Frontiers in Endocrinology
ObjectiveMany researches have demonstrated an association between intra-pancreatic fat deposition (IPFD) and several pancreatic pathological conditions, including pancreatitis, pancreatic cancer, and type 2 diabetes mellitus (T2DM). The aim of this study
Jing Gao, Xiaowu Dong, Xiaolei Shi, Yuqing Yang, Weiwei Chen, Weiming Xiao, Guotao Lu, Xiaoping Yu   +7 more
doaj   +2 more sources

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden

Frontiers in Oncology, 2023
Single-agent immune checkpoint blockade has shown no clinical benefits in pancreatic cancer. Recently, the programmed cell death protein 1 (PD-1) antibody pembrolizumab has been recommended as a treatment option for high tumor mutational burden (TMB ...
Mengyao Dai, Mengyao Dai, Mengyao Dai, Mengyao Dai, Jianpeng Sheng, Jianpeng Sheng, Jianpeng Sheng, Qi Zhang, Qi Zhang, Qi Zhang, Qi Zhang, Jianxin Wang, Jianxin Wang, Jianxin Wang, Jianxin Wang, Qihan Fu, Qihan Fu, Qihan Fu, Qihan Fu, Tingbo Liang, Tingbo Liang, Tingbo Liang, Tingbo Liang   +22 more
doaj   +1 more source